413
Views
43
CrossRef citations to date
0
Altmetric
Drug Profiles

Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy

, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Schuyler Rockwood, Daniel Mason, Ryan Lord, Peter Lamar, Walter Prozialeck & Layla Al-Nakkash. (2019) Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice. Diabetes, Metabolic Syndrome and Obesity 12, pages 2011-2021.
Read now

Articles from other publishers (42)

Claudio Perez‐Leighton, Bredford Kerr, Philipp E. Scherer, René Baudrand & Víctor Cortés. (2023) The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour . Biological Reviews.
Crossref
Jana Křenek Malíková, Irena Aldhoon Hainerová & Jan Lebl. (2023) Current pharmacotherapy options in pediatric obesity. Česko-slovenská pediatrie 78:2, pages 122-126.
Crossref
Valeria Calcaterra, Vittoria Carlotta Magenes, Virginia Rossi, Valentina Fabiano, Chiara Mameli & Gianvincenzo Zuccotti. (2023) Lipodystrophies in non-insulin-dependent children: Treatment options and results from recombinant human leptin therapy. Pharmacological Research 187, pages 106629.
Crossref
Marie Galmiche & Pierre Déchelotte. (2022) Les approches thérapeutiques non invasives de l’obésité : hier, aujourd’hui et demain. Nutrition Clinique et Métabolisme 36:4, pages 226-246.
Crossref
Sara Costa, Lurdes Sampaio, Ana Berta Sousa, Chao Xing, Anil K Agarwal & Abhimanyu Garg. (2022) Face-sparing Congenital Generalized Lipodystrophy Type 1 Associated With Nonclassical Congenital Adrenal Hyperplasia. The Journal of Clinical Endocrinology & Metabolism 107:9, pages 2433-2438.
Crossref
Junqiang J. Tian, Mark Levy, Xuekai Zhang, Robert Sinnott & Rolando Maddela. (2022) Counteracting health risks by Modulating Homeostatic Signaling. Pharmacological Research 182, pages 106281.
Crossref
Francesca Mainieri, Veronica Maria Tagi & Francesco Chiarelli. (2022) Treatment Options for Lipodystrophy in Children. Frontiers in Endocrinology 13.
Crossref
Ryan A. Lafferty, Peter R. Flatt & Nigel Irwin. (2022) Is polypharmacy the future for pharmacological management of obesity?. Current Opinion in Endocrine and Metabolic Research 23, pages 100322.
Crossref
Louise J. Apperley, James Blackburn, Karen Erlandson‐Parry, Lucy Gait, Peter Laing & Senthil Senniappan. (2021) Childhood obesity: A review of current and future management options. Clinical Endocrinology 96:3, pages 288-301.
Crossref
Yue Tong, Sai Xu, Lili Huang & Chen Chen. (2022) Obesity and insulin resistance: Pathophysiology and treatment. Drug Discovery Today 27:3, pages 822-830.
Crossref
Yue Peng, Qianyu Tang, Fan Xiao & Nian Fu. (2022) Regulation of Lipid Metabolism by Lamin in Mutation-Related Diseases. Frontiers in Pharmacology 13.
Crossref
Marinna C Okawa, Elaine Cochran, Marissa Lightbourne & Rebecca J Brown. (2022) Long-Term Effects of Metreleptin in Rabson-Mendenhall Syndrome on Glycemia, Growth, and Kidney Function. The Journal of Clinical Endocrinology & Metabolism 107:3, pages e1032-e1046.
Crossref
Yi Ding, Mariëlle C. Haks, Gabriel Forn-Cuní, Junling He, Natalia Nowik, Amy C. Harms, Thomas Hankemeier, Muhamed N. H. Eeza, Jörg Matysik, A. Alia & Herman P. Spaink. (2021) Metabolomic and transcriptomic profiling of adult mice and larval zebrafish leptin mutants reveal a common pattern of changes in metabolites and signaling pathways. Cell & Bioscience 11:1.
Crossref
Giovanni Ceccarini, Silvia Magno, Donatella Gilio, Caterina Pelosini & Ferruccio Santini. (2021) Autoimmunity in lipodystrophy syndromes. La Presse Médicale 50:3, pages 104073.
Crossref
Yen-Hua Huang, Tzu-Chien Su, Chung-Hsing Wang, Siew-Lee Wong, Yin-Hsiu Chien, Yu-Tai Wang, Wuh-Liang Hwu & Ni-Chung Lee. (2021) RNA-seq of peripheral blood mononuclear cells of congenital generalized lipodystrophy type 2 patients. Scientific Data 8:1.
Crossref
Hany Akeel Al-hussaniy, Ali Hikmate Alburghaif & Meena Akeel Naji. (2021) Leptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions. Journal of Medicine and Life 14:5, pages 600-605.
Crossref
Young Jin Tak & Sang Yeoup Lee. (2021) Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?. Current Obesity Reports 10:1, pages 14-30.
Crossref
José L. Santos & Víctor A. Cortés. (2020) Eating behaviour in contrasting adiposity phenotypes: Monogenic obesity and congenital generalized lipodystrophy. Obesity Reviews 22:1.
Crossref
Pengcheng Zhang, Daniels Konja & Yu Wang. (2020) Adipose tissue secretory profile and cardiometabolic risk in obesity. Endocrine and Metabolic Science 1:3-4, pages 100061.
Crossref
Antonio Pérez-Pérez, Flora Sánchez-Jiménez, Teresa Vilariño-García & Víctor Sánchez-Margalet. (2020) Role of Leptin in Inflammation and Vice Versa. International Journal of Molecular Sciences 21:16, pages 5887.
Crossref
David M. Williams, Asif Nawaz & Marc Evans. (2020) Drug Therapy in Obesity: A Review of Current and Emerging Treatments. Diabetes Therapy 11:6, pages 1199-1216.
Crossref
Shivraj Grewal, Sriram Gubbi, Andin Fosam, Caroline Sedmak, Shanaz Sikder, Harsha Talluru, Rebecca J Brown & Ranganath Muniyappa. (2020) Metabolomic Analysis of the Effects of Leptin Replacement Therapy in Patients with Lipodystrophy. Journal of the Endocrine Society 4:1.
Crossref
Elif A. Oral, Phillip Gorden, Elaine Cochran, David Araújo-Vilar, David B. Savage, Alison Long, Gregory Fine, Taylor Salinardi & Rebecca J. Brown. (2019) Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy. Endocrine 64:3, pages 500-511.
Crossref
Johannes Hebebrand, Gabriella Milos, Martin Wabitsch, Martin Teufel, Dagmar Führer, Judith Bühlmeier, Lars Libuda, Christine Ludwig & Jochen Antel. (2019) Clinical Trials Required to Assess Potential Benefits and Side Effects of Treatment of Patients With Anorexia Nervosa With Recombinant Human Leptin. Frontiers in Psychology 10.
Crossref
Hernan Yupanqui-Lozno, Raul A. Bastarrachea, Maria E. Yupanqui-Velazco, Monica Alvarez-Jaramillo, Esteban Medina-Méndez, Aida P. Giraldo-Peña, Alexandra Arias-Serrano, Carolina Torres-Forero, Angelica M. Garcia-Ordoñez, Claudio A. Mastronardi, Carlos M. Restrepo, Ernesto Rodriguez-Ayala, Edna J. Nava-Gonzalez, Mauricio Arcos-Burgos, Jack W. KentJr.Jr., Shelley A. Cole, Julio Licinio & Luis G. Celis-Regalado. (2019) Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity. Genes 10:5, pages 342.
Crossref
Emma Deeks. (2019) Metreleptin in lipodystrophy: a profile of its use. Drugs & Therapy Perspectives 35:5, pages 201-208.
Crossref
Miwako Maeda, Tomoki Maeda, Ken Ebihara & Kenji Ihara. (2019) The long-term management of congenital generalized lipodystrophy (Berardinelli-Seip syndrome): the clinical manifestations of Japanese siblings for approximately 20 years. Clinical Pediatric Endocrinology 28:4, pages 139-145.
Crossref
Rai-Hseng Hsu, Wei-De Lin, Mei-Chyn Chao, Hui-Pin Hsiao, Siew-Lee Wong, Pao-Chin Chiu, Shao-Yin Chu, Yu-Yuan Ke, Beng-Huat Lau, Yin-Hsiu Chien, Wuh-Liang Hwu, Fuu-Jen Tsai, Chung-Hsing Wang & Ni-Chung Lee. (2019) Congenital generalized lipodystrophy in Taiwan. Journal of the Formosan Medical Association 118:1, pages 142-147.
Crossref
D. Araújo-Vilar & F. Santini. (2018) Diagnosis and treatment of lipodystrophy: a step-by-step approach. Journal of Endocrinological Investigation 42:1, pages 61-73.
Crossref
Baris Akinci, Rasimcan Meral & Elif Arioglu Oral. (2018) Update on Therapeutic Options in Lipodystrophy. Current Diabetes Reports 18:12.
Crossref
Ann Hammarstedt, Silvia Gogg, Shahram Hedjazifar, Annika Nerstedt & Ulf Smith. (2018) Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiological Reviews 98:4, pages 1911-1941.
Crossref
Gitanjali Srivastava & Caroline Apovian. (2018) Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon. Current Obesity Reports 7:2, pages 147-161.
Crossref
Rebecca J. Brown, Elif A. Oral, Elaine Cochran, David Araújo-Vilar, David B. Savage, Alison Long, Gregory Fine, Taylor Salinardi & Phillip Gorden. (2018) Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy. Endocrine 60:3, pages 479-489.
Crossref
Laura Papendieck & María B. Araujo. (2018) Clinical outcome in a series of pediatric patients with congenital generalized lipodystrophies treated with dietary therapy. Journal of Pediatric Endocrinology and Metabolism 31:1, pages 77-83.
Crossref
Rachel C. Morgan & Robert V. Considine. 2018. Encyclopedia of Endocrine Diseases. Encyclopedia of Endocrine Diseases 420 427 .
Lanhui Huang, Hong Shi & Xinli Zhou. (2017) Mechanistic Insights into Osteoporosis in Patients with Lipodystrophy and Review of the Literature. Endocrine Practice 23:7, pages 857-862.
Crossref
Rebecca J. Brown, Cristina Adelia Meehan, Elaine Cochran, Kristina I. Rother, David E. Kleiner, Mary Walter & Phillip Gorden. (2017) Effects of Metreleptin in Pediatric Patients With Lipodystrophy. The Journal of Clinical Endocrinology & Metabolism 102:5, pages 1511-1519.
Crossref
Nelson Purizaca-Rosillo, Takayasu Mori, Yamali Benites-Cóndor, Fuki M. Hisama, George M. Martin & Junko Oshima. (2017) High incidence of BSCL2 intragenic recombinational mutation in Peruvian type 2 Berardinelli-Seip syndrome . American Journal of Medical Genetics Part A 173:2, pages 471-478.
Crossref
Fabrizio Barbetti, Carlo Colombo, Leena Haataja, Corentin Cras-Méneur, Sergio Bernardini & Peter Arvan. (2016) Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?. Clinical Diabetes and Endocrinology 2:1.
Crossref
Jeffrey Friedman. (2016) The long road to leptin. Journal of Clinical Investigation 126:12, pages 4727-4734.
Crossref
Vani P. Sanon, Yehuda Handelsman, Son V. Pham & Robert Chilton. (2016) Cardiac Manifestations of Congenital Generalized Lipodystrophy. Clinical Diabetes 34:4, pages 181-186.
Crossref
Carmelo Quarta, Miguel A. Sánchez-Garrido, Matthias H. Tschöp & Christoffer Clemmensen. (2016) Renaissance of leptin for obesity therapy. Diabetologia 59:5, pages 920-927.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.